These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5536898)

  • 1. Ocular pigment deposits: drug-induced false-positives.
    Clark ML; Serafetinides EA; Wise JB; Colmore JP
    JAMA; 1970 Dec; 214(13):2339. PubMed ID: 5536898
    [No Abstract]   [Full Text] [Related]  

  • 2. [False-positive ocular pigmentation during administration of neuroleptics].
    Tidsskr Nor Laegeforen; 1971 Dec; 91(35):2575-6. PubMed ID: 4945027
    [No Abstract]   [Full Text] [Related]  

  • 3. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract]   [Full Text] [Related]  

  • 4. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
    [No Abstract]   [Full Text] [Related]  

  • 5. Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
    Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM
    Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular complications of phenothiazines.
    Mathalone MB
    Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation of chlorpromazine pigments in man.
    Van Woert MH
    Nature; 1968 Sep; 219(5158):1054-6. PubMed ID: 5673364
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous and ocular changes associated with the use of chlorpromazine.
    Wolf ME; Richer S; Berk MA; Mosnaim AD
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular effects of phenothiazine derivatives and reversibility.
    Mathalone MB
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
    [No Abstract]   [Full Text] [Related]  

  • 10. An animal model for chlorpromazine-induced hyperpigmentation of the skin.
    Forrest IS; Aber RC; Kosek JC; Serra MT
    Proc West Pharmacol Soc; 1969; 12():36-40. PubMed ID: 5812296
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ultrastructural study of ocular pigmentation due to phenothiazines].
    Sizaret P; Rossazza C; Brassart B
    Rev Otoneuroophtalmol; 1975; 47(4):247-51. PubMed ID: 1215727
    [No Abstract]   [Full Text] [Related]  

  • 12. Autofluorescence emission spectra of dermal lipofuscinosis associated with amiodarone therapy.
    Dowson JH; Miller RA; McDonald AT
    Arch Dermatol; 1986 Mar; 122(3):244-5. PubMed ID: 3954387
    [No Abstract]   [Full Text] [Related]  

  • 13. A CLINICAL STUDY OF PIGMENTARY CHANGE IN CORNEA AND LENS IN CHRONIC CHLORPROMAZINE THERAPY.
    WETTERHOLM DH; SNOW HL; WINTER FC
    Arch Ophthalmol; 1965 Jul; 74():55-6. PubMed ID: 14303344
    [No Abstract]   [Full Text] [Related]  

  • 14. [Histological development of intracutaneous deposits induced by amiodarone].
    Labouche F; Balouet G; Daoulas R; Picart D
    Bull Soc Fr Dermatol Syphiligr; 1972; 79(1):23-6. PubMed ID: 4641732
    [No Abstract]   [Full Text] [Related]  

  • 15. [Crystalline lens luxation and pigment migration].
    Soyeux A; Debrousse JY
    Bull Soc Ophtalmol Fr; 1979; 79(6-7):623. PubMed ID: 317578
    [No Abstract]   [Full Text] [Related]  

  • 16. [Deposition of colored lipids in the skin, following phenacetin abuse].
    Berneis K; Studer A
    Virchows Arch B Cell Pathol; 1969; 2(4):311-7. PubMed ID: 4977425
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid gland pigmentation and minocycline therapy.
    Gordon G; Sparano BM; Kramer AW; Kelly RG; Iatropoulos MJ
    Am J Pathol; 1984 Oct; 117(1):98-109. PubMed ID: 6435454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermal lipofuscinosis associated with amiodarone therapy. Report of a case.
    Miller RA; McDonald AT
    Arch Dermatol; 1984 May; 120(5):646-9. PubMed ID: 6721527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abnormally high tissue levels of brown pigment under amiodarone administration].
    Barchewitz G; Laurent G; Jamaer M
    Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):59-67. PubMed ID: 4194559
    [No Abstract]   [Full Text] [Related]  

  • 20. Melanins and lens pigments: a comparative study.
    Cuevas AA; García-Castiñeiras S
    P R Health Sci J; 1993 Jun; 12(2):129-35. PubMed ID: 8210284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.